Helen O McCarthy
Overview
Explore the profile of Helen O McCarthy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2665
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li L, Zhao L, Li M, Tao Y, Sabri A, Moreno-Castellanos N, et al.
ACS Appl Mater Interfaces
. 2025 Mar;
PMID: 40048359
Schizophrenia is one of the most severe mental disorders, affecting approximately 24 million people worldwide. Conventional treatments, such as drug-loaded implants and intramuscular injections, have several limitations, including pain during...
2.
Lin G, Elkashif A, Saha C, Coulter J, Dunne N, McCarthy H
Crit Rev Oncol Hematol
. 2025 Feb;
208:104643.
PMID: 39900315
Prostate cancer has the second highest cancer mortality rate in the UK in males. Early prostate cancer is typically asymptomatic, with diagnosis at a locally advanced or metastatic stage. In...
3.
Sadat Hashemi T, Jaiswal S, McCarthy H, Levingstone T, Dunne N
Biomater Adv
. 2025 Jan;
169:214170.
PMID: 39793150
Magnesium (Mg) alloys have gained significant attention as a desirable choice of biodegradable implant for use in bone repair applications, largely owing to their unique material properties. More recently, Mg...
4.
Pentlavalli S, Coulter S, An Y, Cross E, Sun H, Moore J, et al.
J Control Release
. 2024 Dec;
379:30-44.
PMID: 39724948
New multipurpose prevention technology products for use by women, focused on reducing HIV infection and preventing unwanted pregnancies, are a global health priority. Discreet long-acting formulations will empower women with...
5.
Sutcliffe R, Doherty C, Morgan H, Dunne N, McCarthy H
Biomater Adv
. 2024 Dec;
169:214153.
PMID: 39705787
Cell-penetrating peptides (CPP) have gained rapid attention over the last 25 years; this is attributed to their versatility, customisation, and 'Trojan horse' delivery that evades the immune system. However, the...
6.
Li L, Anjani Q, Hutton A, Li M, Sabri A, Vora L, et al.
Drug Deliv Transl Res
. 2024 Nov;
PMID: 39565514
Hydrogel-forming microneedle (MN) arrays are minimally-invasive devices that can penetrate the stratum corneum, the main barrier to topical drug application, without causing pain. However, drug delivery using hydrogel-forming MN arrays...
7.
Peterson B, Canonicco Castro M, McCarthy H, Buckley N, Dunne N, Rolfe R, et al.
Acta Biomater
. 2024 Oct;
190:303-316.
PMID: 39395701
There is an abrupt increase in the multiscale mechanical properties and load-bearing capabilities of tendon during development. While prior work has identified numerous changes that occur within the collagenous structure...
8.
Graham J, Castro J, Werba L, Fardone L, Francis K, Ramamurthi A, et al.
bioRxiv
. 2024 Oct;
PMID: 39386541
CRISPR gene editing offers unprecedented genomic and transcriptomic control for precise regulation of cell function and phenotype. However, delivering the necessary CRISPR components to therapeutically relevant cell types without cytotoxicity...
9.
Naser Y, Vora L, Tekko I, Peng K, Volpe-Zanutto F, Greer B, et al.
ACS Appl Mater Interfaces
. 2024 Oct;
PMID: 39356645
The increasing popularity of prolonged-release dosage forms, owing to their ability to provide continuous drug release after administration, has significantly improved patient compliance and overall quality of life. However, achieving...
10.
Qin N, Li M, Vora L, Peng K, Sabri A, Tao Y, et al.
Int J Pharm
. 2024 Sep;
665:124691.
PMID: 39278288
Hyperlipidemia and its associated cardiovascular complications are the major causes of mortality and disability worldwide. Simvastatin (SIM) is one of the most commonly prescribed lipid-lowering drugs for the treatment of...